Forge Biologics
June 16, 2025
Company Presentation
Contract Manufacturing Organization
Forge Biologics, a member of Ajinomoto Bio-Pharma Services, is a gene therapy contract development and manufacturing organization (CDMO) enabling access to life-changing gene therapies by bringing them from concept to reality. Forge’s 200,000 square foot facility, the Hearth, is headquartered in Columbus, Ohio, and houses 20 custom-designed cGMP suites with 20,000L of bioreactor capacity. Forge’s end-to-end, scalable plasmid and AAV manufacturing services include research-grade manufacturing, process and analytical development, cGMP manufacturing, fill and finish, and integrated regulatory support to help accelerate the timelines of transformative medicines for patients with genetic diseases. To learn more, visit www.forgebiologics.com.
Company HQ City:
Grove City
Company HQ State:
Ohio
Company HQ Country:
United States
Year Founded:
2021
Lead Product in Development:
n/a
CEO
John Maslowski
Year Founded
2021
Development Phase of Lead Product
Other/Not Applicable
Number of Unlicensed Products Looking for Licensing
n/a
Exchange
Tokyo Stock Exchange (TSE)
Ticker
2802
When you expect your next catalyst update?
Undisclosed
What is your next catalyst (value inflection) update?
Undisclosed
Website
https://www.forgebiologics.com/
Primary Speaker
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}